Stephen M. Ansell, MD, PhD

Articles by Stephen M. Ansell, MD, PhD

Stephen M. Ansell, MD, PhD, on Integrating Cell Therapy into Clinical Practice in Oncology

ByStephen M. Ansell, MD, PhD,Noah Stansfield

November 18th 2025

The chair of the Division of Hematology at Mayo Clinic discussed practical considerations for the introduction of cell therapies for the treatment of hematologic malignancies.

Immunotherapy and CAR T-Cell Therapy: Stephen M. Ansell, MD, PhD

ByStephen M. Ansell, MD, PhD

August 17th 2021

The chair of the Lymphoma Group at Mayo Clinic discussed incorporating immunotherapies beyond CAR T-cell therapy in non-Hodgkin lymphoma.

Stephen M. Ansell, MD, PhD, on Progress of CAR T-Cell Therapy

ByStephen M. Ansell, MD, PhD

December 12th 2019

The Mayo Clinic expert highlights exciting advancements being made in chimeric antigen receptor T-cell therapy for blood cancer.

Dr. Ansell on Combining CAR T-cell Therapy and Immunotherapy in Lymphomas

ByStephen M. Ansell, MD, PhD

August 3rd 2017

Stephen M. Ansell, MD, PhD, chair of the Lymphoma Group at Mayo Clinic, discusses the possibility of blending immunotherapy agents with chimeric antigen receptor (CAR) T-cell therapy across lymphoma populations.